Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography
May 26th, 2015
351 views
Ex vivo analysis of arterial lesions from animal models of cardiovascular disease classically relies on histological and immunohistochemical techniques. These provide 2-dimensional measurements in 3-dimensional lesions. This manuscript describes the generation of arterial lesions for quantitative analysis in 3-dimensions using optical projection tomography.
Overview
This article demonstrates the use of optical projection tomography (OPT) for the visualization and quantification of arterial lesions in mice. The method allows for three-dimensional analysis of atherosclerotic and neointimal lesions, providing insights into the mechanisms of arterial narrowing.
Key Study Components
Area of Science
- Cardiovascular disease
- Optical imaging techniques
- Animal models of atherosclerosis
Background
- Traditional methods rely on histology and immunohistochemistry.
- These methods provide limited two-dimensional measurements.
- OPT offers a less labor-intensive alternative.
- Understanding arterial lesions is crucial for addressing heart attack and stroke risks.
Purpose of Study
- To visualize and quantify arterial lesions in three dimensions.
- To improve understanding of lesion formation mechanisms.
- To demonstrate a novel technique developed by the research team.
Methods Used
- Induction of arterial lesions in mice via surgery or high cholesterol diet.
- Isolation of target arteries for scanning with OPT.
- Image reconstruction and analysis to measure lesion volume.
- Comparison of OPT with traditional histological methods.
Main Results
- Successful visualization of atherosclerotic lesions in three dimensions.
- Quantification of lesion volume and arterial narrowing achieved.
- Demonstrated advantages of OPT over existing techniques.
- Provided anatomical reconstructions of arterial lesions.
Conclusions
- OPT is a valuable tool for studying arterial lesions.
- It enhances the understanding of cardiovascular disease mechanisms.
- The technique may lead to improved therapeutic strategies.
Frequently Asked Questions
What is optical projection tomography?
Optical projection tomography (OPT) is an imaging technique that allows for three-dimensional visualization and quantification of biological structures.
How are arterial lesions induced in the study?
Arterial lesions are induced in mice either surgically or by feeding them a high cholesterol diet.
What are the advantages of using OPT?
OPT is less labor-intensive than traditional histological methods and provides three-dimensional analysis of lesions.
What types of lesions are analyzed using this method?
The method is used to analyze atherosclerotic and neointimal lesions in arterial tissues.
Who developed the technique demonstrated in the study?
The technique was developed by Dr. Nicholas Kirkby and Dr. Lucy Lowe, and demonstrated by Dr. Jung Shi Wu.
What is the significance of quantifying lesion volume?
Quantifying lesion volume helps in understanding the severity of arterial narrowing and its implications for cardiovascular health.
Executive Industry Relevance
Optical projection tomography (OPT) enables three-dimensional quantification of arterial lesions in preclinical models, addressing a critical gap in cardiovascular disease research. By providing volumetric data complementary to histology, OPT improves predictive confidence in lesion characterization and supports mechanistic de-risking of therapeutic targets. This capability enhances translational continuity from discovery through preclinical validation, informing risk-adjusted advancement decisions in atherosclerosis and restenosis programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by visualizing lesion formation in surgically induced and diet-induced models.
- Operational Value: Supports functional target validation through non-destructive, volumetric assessment of neointimal and atherosclerotic burden.
- Predictive Value: Facilitates portfolio triage by quantifying lesion volume and arterial narrowing as objective efficacy endpoints.
Screening & Assay Development
- Scientific Value: Generates standardized, quantitative lesion metrics suitable for assay development in vascular remodeling studies.
- Operational Value: Delivers reproducible, ex vivo imaging outputs that reduce variability compared to 2D histological sectioning.
- Scalability: Enables platform reuse across lesion models (wire injury, ligation, apoE-deficient diet) for consistent compound evaluation.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery and preclinical validation by providing 3D lesion data aligned with histological and immunohistochemical analysis.
- Mechanistic De-risking: Clarifies spatial distribution of lesions in aortic arch branches, supporting target engagement studies.
- Risk-Adjusted Decisions: Enables objective comparison of lesion burden across experimental groups to inform go/no-go criteria.
Pipeline & Workflow Integration
OPT fits within the discovery continuum from target validation through preclinical assessment, offering volumetric lesion quantification that complements endpoint histology. The method supports hypothesis testing in vascular biology by enabling direct visualization of lesion formation mechanisms in relevant mouse models.
- Discovery Biology: Supports pathway clarification by distinguishing lesion composition and distribution in femoral artery and aortic arch models.
- Screening: Delivers assay-ready, quantitative outputs (lesion volume, luminal area) for reliable compound screening in restenosis and atherosclerosis models.
- Analytics: Provides volumetric measurements and cross-sectional area calculations that enable statistical comparison of treatment effects.
- Translational Research: Connects to preclinical continuity through correlative analysis with histology, enhancing biomarker alignment for lesion burden.
- Enterprise Reuse: Establishes a reusable imaging capability for cardiovascular discovery programs requiring ex vivo 3D phenotyping.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in lesion formation.
- Operational Value: Improves standardization and reproducibility of lesion quantification across laboratories and study sites.
- Strategic Value: Enhances capital efficiency by enabling earlier go/no-go decisions based on objective volumetric endpoints.
- Portfolio Impact: Supports risk-adjusted prioritization of vascular therapies through accurate lesion burden assessment.
Implementation Considerations
- Requires expertise in optical imaging, tissue clearing, and 3D reconstruction software.
- Dependent on OPT instrumentation capable of 1024x1024 resolution and GFP emission channel detection.
- Necessitates standardization of tissue preparation protocols (fixation, dehydration, clearing) across model systems.
- Involves adaptation considerations for different arterial beds (femoral, aortic arch) and lesion types (neointimal, atherosclerotic).
- Limited by ex vivo application; cannot be used for longitudinal in vivo monitoring.
Biopharma FAQs
Why does lesion volume quantification matter for target validation?
Quantifying lesion volume provides an objective, three-dimensional measure of therapeutic efficacy in preclinical models. This enables more accurate assessment of target engagement compared to two-dimensional histological methods. Volumetric data supports go/no-go decisions by reducing variability in lesion burden evaluation.
How does isolating the target artery improve discovery pipeline efficiency?
Isolating the femoral artery or aortic arch ensures consistent region-of-interest selection for OPT scanning. This standardization minimizes anatomical variability and improves reproducibility across experimental groups. Precise isolation enables reliable comparison of lesion development between control and treatment conditions.
What do quantitative dependent variable measurements enable in vascular studies?
Quantitative measurements of lesion volume and luminal area enable statistical comparison of treatment effects across groups. These metrics provide continuous endpoints suitable for dose-response analysis and power calculations. Objective volumetrics reduce reliance on subjective histological scoring, improving data robustness.
Why do replication requirements matter for cross-functional collaboration?
Replication requirements ensure that OPT-derived lesion measurements are consistent across laboratories and study sites. Standardized protocols for tissue preparation and imaging facilitate data sharing between discovery, preclinical, and translational teams. Consistent volumetrics support aligned decision-making in cardiovascular drug development programs.
What statistical analysis capabilities are required before implementing OPT?
Implementation requires capability to analyze volumetric data using statistical tests for group comparisons (e.g., t-tests, ANOVA). Software must support lesion segmentation, volume calculation, and luminal area quantification from OPT reconstructions. Analytical workflows should integrate OPT outputs with histological data for correlative validation.
